Status:
UNKNOWN
Cancer Predictive Score on Breast MRI
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
Sometimes, breast ultrasound and mammographic can't be diagnose suspsious lesions ( no substratum). So a MRI-guided breast biopsy is perfomed and disclosed ultimately benign lesions. The aim of this ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- women aged 18 and more
- performed MRI-guided breast biopsy
- Exclusion criteria:
- \- Not MRI-guided breast biopsy
Exclusion
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2022
Estimated Enrollment :
428 Patients enrolled
Trial Details
Trial ID
NCT04914494
Start Date
January 1 2021
End Date
September 30 2022
Last Update
January 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295